Well Lead Med Co Ltd Total Assets

Latest as of June 2026: CN¥2.73 Billion CNY ≈ $398.78 Million USD

Well Lead Med Co Ltd total assets. Based on the latest financial reports, Well Lead Med Co Ltd (603309) holds total assets worth CN¥2.73 Billion CNY (≈ $398.78 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Well Lead Med Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Total Assets of Well Lead Med Co Ltd (2011–2025)

Total assets of Well Lead Med Co Ltd from 2011 to 2025. This chart illustrates how Well Lead Med Co Ltd's total assets have evolved over time, based on quarterly financial data. See Well Lead Med Co Ltd stock price for real-time trading data and today's change.

Well Lead Med Co Ltd - Asset Composition Analysis

Well Lead Med Co Ltd Total Assets Breakdown (December 2025)

Well Lead Med Co Ltd total assets breakdown as of December 2025. Well Lead Med Co Ltd's total assets of CN¥2.73 Billion consist of 33.8% current assets and 66.2% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 8.9%
Accounts Receivable CN¥212.15 Million 7.4%
Inventory CN¥189.05 Million 6.6%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥170.48 Million 6.0%
Goodwill CN¥145.58 Million 5.1%

Asset Composition Trend (2011–2025)

This chart illustrates how Well Lead Med Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Well Lead Med Co Ltd current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Well Lead Med Co Ltd's current assets represent 33.8% of total assets in 2025, a decrease from 53.0% in 2011.
  • Cash Position: Cash and equivalents constituted 8.9% of total assets in 2025, down from 16.4% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 12.0% in 2011.
  • Asset Diversification: The largest asset category is accounts receivable at 7.4% of total assets.

Well Lead Med Co Ltd Competitors by Total Assets

Key competitors of Well Lead Med Co Ltd based on total assets are shown below.

Company Country Total Assets
SARTORIUS (UNSP.ADS)/1/5
F:SRT0
Germany €9.87 Billion
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
iRay Technology Co Ltd
SHG:688301
China CN¥11.33 Billion
Guangzhou Improve Med Instrument
SHE:300030
China CN¥1.02 Billion
Medeon Biodesign
TWO:6499
Taiwan NT$1.55 Billion
Ansell Ltd
AU:ANN
Australia AU$3.39 Billion
Nanosonics Ltd
AU:NAN
Australia AU$279.25 Million
SDI Ltd
AU:SDI
Australia AU$135.84 Million

Well Lead Med Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.74 1.78 1.64
Quick Ratio 1.33 1.38 1.11
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥362.90 Million CN¥390.81 Million CN¥192.96 Million

Well Lead Med Co Ltd - Advanced Valuation Insights

This section examines the relationship between Well Lead Med Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.82
Latest Market Cap to Assets Ratio 0.16
Asset Growth Rate (YoY) 0.7%
Total Assets CN¥2.86 Billion
Market Capitalization $456.57 Million USD

Valuation Analysis

Below Book Valuation: The market values Well Lead Med Co Ltd's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Well Lead Med Co Ltd's assets grew by 0.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Well Lead Med Co Ltd (2011–2025)

The table below shows the annual total assets of Well Lead Med Co Ltd from 2011 to 2025.

Year Total Assets Change
2025-12-31 CN¥2.86 Billion
≈ $418.57 Million
+0.70%
2024-12-31 CN¥2.84 Billion
≈ $415.68 Million
+9.04%
2023-12-31 CN¥2.61 Billion
≈ $381.23 Million
+9.30%
2022-12-31 CN¥2.38 Billion
≈ $348.80 Million
+11.78%
2021-12-31 CN¥2.13 Billion
≈ $312.03 Million
+43.23%
2020-12-31 CN¥1.49 Billion
≈ $217.85 Million
+2.27%
2019-12-31 CN¥1.46 Billion
≈ $213.02 Million
+2.92%
2018-12-31 CN¥1.41 Billion
≈ $206.98 Million
+39.95%
2017-12-31 CN¥1.01 Billion
≈ $147.90 Million
+3.91%
2016-12-31 CN¥972.68 Million
≈ $142.33 Million
+10.40%
2015-12-31 CN¥881.08 Million
≈ $128.93 Million
+67.57%
2014-12-31 CN¥525.80 Million
≈ $76.94 Million
+11.04%
2013-12-31 CN¥473.51 Million
≈ $69.29 Million
+15.73%
2012-12-31 CN¥409.14 Million
≈ $59.87 Million
+12.00%
2011-12-31 CN¥365.30 Million
≈ $53.45 Million
--

About Well Lead Med Co Ltd

SHG:603309 China Medical Instruments & Supplies
Market Cap
$456.57 Million
CN¥3.12 Billion CNY
Market Cap Rank
#12354 Global
#3511 in China
Share Price
CN¥10.69
Change (1 day)
+0.38%
52-Week Range
CN¥10.60 - CN¥15.95
All Time High
CN¥33.54
About

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more